Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$144,027
-$14,854 QoQ
Shares Held
1,140
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,956
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avalon Trust Co holds $14,903,557 across 12 Drug Manufacturers - General names. GILD ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,254 | $10,477,278 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,249 | $1,702,496 | |
| 3 | LLY |
ELI LILLY & Co
|
799 | $958,344 | |
| 4 | ABBV |
AbbVie Inc.
|
3,666 | $922,512 | |
| 5 | NVS |
Novartis AG
|
1,900 | $297,768 | |
| 6 | AZN |
Astrazeneca PLC
|
774 | $146,765 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,140 | $144,027 | |
| 8 | NVO |
Novo Nordisk A S
|
2,000 | $95,880 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,027 | 1,140 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $158,881 | 1,140 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $142,132 | 1,158 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $139,638 | 1,258 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $126,391 | 1,140 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||